Skip to search formSkip to main contentSkip to account menu

E 3123

Known as: E-3123, E3123 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Protease inhibitors may have a beneficial effect in acute pancreatitis. The effects of E3123, a new low molecular weight protease… 
1995
1995
OBJECTIVE To evaluate the protective effects of combined prophylaxis with 4-sulfamoylphenyl, 4-guanidinobenzoate methanesulfonate… 
1994
1994
Blockage of the rat pancreatico-biliary duct (PBDO) for 4 hours and secretin infusion (0.2 CU [Clinical Unit]/kg/hr) caused… 
1994
1994
The effect of a novel synthetic trypsin inhibitor, 4-(2-succinimidoethylthio)-phenyl 4-guanidinobenzoate methanesulfonate (E3123… 
1994
1994
SummaryThe intracellular distribution and action of a new synthetic protease inhibitor, E3123, were studied in cerulein-induced… 
1993
1993
Abstract The role of infectious factors in the pathogenesis of acute pancreatitis and the protective effect of combined therapy… 
1992
1992
This study was designed to evaluate the acute toxic effects of cyclosporin A on the exocrine pancreas and the protective effects… 
1990
1990
The effects of intravenous infusion of 4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate (E-3123), a new synthetic protease… 
1989
1989
It was found that [4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate]methanesulfonate (E-3123) inhibits trypsin, thrombin and… 
1988
1988
4-(2-Succinimidoethylthio) phenyl 4-guanidinobenzoate (E-3123) potently inhibited trypsin, plasmin and thrombin with IC50 values…